Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

Novartis and Microsoft test Kinect MS tool

The partners have a proof-of-concept for a system that could measure the condition's symptoms

AstraZeneca AZ global R&D corporate HQ

AZ’s influenza drug fast tracked in US

FDA expedites MEDI8852 to help meet an acute need for new flu treatments

- PMLiVE

FDA clears Imbruvica as chemo alternative for first-line CLL

Johnson & Johnson/AbbVie's first-in-class drug now approved for all CLL patients

- PMLiVE

Consilium wins Allergy Therapeutics account

Will advise the firm on international investor relations

J&J’s portent of purity

The future of corporate structures is emerging before our eyes

National Institute for Health and Care Excellence NICE logo

NICE’s rejection of Imbruvica ‘reveals appraisal process flaws’

Leukaemia charity says the cost-effectiveness body can't cope with uncertainty

AstraZeneca AZ global R&D corporate HQ

AZ offloads more products in slimming drive

Will invest Moventig, Plendil and Imdur proceeds in its R&D pipeline

- PMLiVE

Paging Dr Millennial

How do millennial doctors compare to previous generations of doctors?

- PMLiVE

Under pressure

Six inexorable forces shaping our industry's evolution

Seven ways to make centrally-produced content fit affiliates’ needs

It’s common to encounter some degree of local resistance to centrally-produced sales materials. But don’t despair. A few simple content strategies can make a huge difference. Here are seven ideas...

Anthill Agency

- PMLiVE

Lucid Group celebrate 9 years of changing patients’ lives

Lucid Group had fun and games celebrating their nine year anniversary in their London offices last week. Lucid has grown from the two founders working out of a basement to...

Lucid Group Communications Limited

Infographic: HCV EU

Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.Our latest market snapshot offers an introduction...

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links